Flux Enhancement in Continuous Glucose Monitoring
OwnerJanet Tamada, Arvind N. Jina +1inventors
InventorsJanet Tamada, Arvind N. Jina, Jonathan Lee
Life of this patent
Estimating the term…
Loading patent…
OwnerJanet Tamada, Arvind N. Jina +1inventors
InventorsJanet Tamada, Arvind N. Jina, Jonathan Lee
Estimating the term…
One aspect of the invention is a method of in vivo monitoring of an individual's interstitial fluid glucose concentration comprising inserting a plurality of tissue piercing elements through a stratum corneum layer of an area of the individual's skin. The tissue piercing elements each comprise a distal end in fluid communication with interstitial fluid of the individual, and a proximal end in fluid communication with a sensing zone located outside of the patient's body. An interior space extends between the distal and proximal ends of the tissue piercing elements. A sensing fluid fills substantially the entire interior space and the sensing fluid concentration comprises a concentration of citrate in a buffer solution. The concentration of citrate may range from 100 mM to 200 mM, preferably 135-165 mM.
A method of in vivo monitoring of an individual's interstitial fluid analyte concentration comprising:
An analyte monitor comprising:
Dependencies are inferred from the claim text.